APO Research

APO RESEARCH · REPORT

5G for Medical

Selected research

Market Analysis & Forecast

Global 5G for Medical Market Analysis and Forecast 2026-2032

Market perspective

The global 5G for Medical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for 5G for Medical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for 5G for Medical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for 5G for Medical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for 5G for Medical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of 5G for Medical include AT&T, Capsule Technologies, Microsoft, Intel Corporation, Cisco, Accenture, Verizon Communications, Ericsson and Oracle, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for 5G for Medical, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of 5G for Medical, also provides the revenue of main regions and countries. Of the upcoming market potential for 5G for Medical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the 5G for Medical revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global 5G for Medical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for 5G for Medical revenue, projected growth trends, production technology, application and end-user industry.

5G for Medical Segment by Company

AT&T

Capsule Technologies

Microsoft

Intel Corporation

Cisco

Accenture

Verizon Communications

Ericsson

Oracle

Juniper Networks

Nokia

Samsung Electronics

NEC

Huawei

ZTE

5G for Medical Segment by Type

Patient Monitoring

Remote Diagnosis

Robotic surgery (Procedures)

Others(Remote Medical Learning)

5G for Medical Segment by Application

Hospital

Home Healthcare

Educational Institution

Others

5G for Medical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 5G for Medical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 5G for Medical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 5G for Medical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of 5G for Medical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of 5G for Medical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 5G for Medical revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global 5G for Medical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Patient Monitoring Major Player Table 3. Remote Diagnosis Major Player Table 4. Robotic surgery (Procedures) Major Player Table 5. Others(Remote Medical Learning) Major Player Table 6. Global 5G for Medical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Home Healthcare Major Player Table 9. Educational Institution Major Player Table 10. Others Major Player Table 11. 5G for Medical Industry Trends Table 12. 5G for Medical Industry Drivers Table 13. 5G for Medical Industry Opportunities and Challenges Table 14. 5G for Medical Industry Restraints Table 15. Global 5G for Medical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global 5G for Medical Market Size by Region (2021-2026) & (US$ Million) Table 17. Global 5G for Medical Market Share by Region (2021-2026) Table 18. Global 5G for Medical Market Size by Region (2027-2032) & (US$ Million) Table 19. Global 5G for Medical Market Share by Region (2027-2032) Table 20. Global 5G for Medical Revenue by Players (US$ Million) & (2021-2026) Table 21. Global 5G for Medical Revenue Market Share by Players (2021-2026) Table 22. Global 5G for Medical Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global 5G for Medical Key Players Headquarters & Area Served Table 24. Global 5G for Medical Players, Product Type & Application Table 25. Global 5G for Medical Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global 5G for Medical by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global 5G for Medical Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global 5G for Medical Revenue by Type (2021-2026) & (US$ Million) Table 30. Global 5G for Medical Revenue by Type (2027-2032) & (US$ Million) Table 31. Global 5G for Medical Revenue Market Share by Type (2021-2026) Table 32. Global 5G for Medical Revenue Market Share by Type (2027-2032) Table 33. Global 5G for Medical Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global 5G for Medical Revenue by Application (2021-2026) & (US$ Million) Table 35. Global 5G for Medical Revenue by Application (2027-2032) & (US$ Million) Table 36. Global 5G for Medical Revenue Market Share by Application (2021-2026) Table 37. Global 5G for Medical Revenue Market Share by Application (2027-2032) Table 38. AT&T Company Information Table 39. AT&T Business Overview Table 40. AT&T 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. AT&T 5G for Medical Product Portfolio Table 42. AT&T Recent Development Table 43. Capsule Technologies Company Information Table 44. Capsule Technologies Business Overview Table 45. Capsule Technologies 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Capsule Technologies 5G for Medical Product Portfolio Table 47. Capsule Technologies Recent Development Table 48. Microsoft Company Information Table 49. Microsoft Business Overview Table 50. Microsoft 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Microsoft 5G for Medical Product Portfolio Table 52. Microsoft Recent Development Table 53. Intel Corporation Company Information Table 54. Intel Corporation Business Overview Table 55. Intel Corporation 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Intel Corporation 5G for Medical Product Portfolio Table 57. Intel Corporation Recent Development Table 58. Cisco Company Information Table 59. Cisco Business Overview Table 60. Cisco 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Cisco 5G for Medical Product Portfolio Table 62. Cisco Recent Development Table 63. Accenture Company Information Table 64. Accenture Business Overview Table 65. Accenture 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Accenture 5G for Medical Product Portfolio Table 67. Accenture Recent Development Table 68. Verizon Communications Company Information Table 69. Verizon Communications Business Overview Table 70. Verizon Communications 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Verizon Communications 5G for Medical Product Portfolio Table 72. Verizon Communications Recent Development Table 73. Ericsson Company Information Table 74. Ericsson Business Overview Table 75. Ericsson 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Ericsson 5G for Medical Product Portfolio Table 77. Ericsson Recent Development Table 78. Oracle Company Information Table 79. Oracle Business Overview Table 80. Oracle 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Oracle 5G for Medical Product Portfolio Table 82. Oracle Recent Development Table 83. Juniper Networks Company Information Table 84. Juniper Networks Business Overview Table 85. Juniper Networks 5G for Medical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Juniper Networks 5G for Medical Product Portfolio Table 87. Juniper Networks Recent Development Table 88. Nokia Company Information Table 89. Nokia Business Overview Table 90. Nokia 5G for Medical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Nokia 5G for Medical Product Portfolio Table 92. Nokia Recent Development Table 93. Samsung Electronics Company Information Table 94. Samsung Electronics Business Overview Table 95. Samsung Electronics 5G for Medical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Samsung Electronics 5G for Medical Product Portfolio Table 97. Samsung Electronics Recent Development Table 98. NEC Company Information Table 99. NEC Business Overview Table 100. NEC 5G for Medical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. NEC 5G for Medical Product Portfolio Table 102. NEC Recent Development Table 103. Huawei Company Information Table 104. Huawei Business Overview Table 105. Huawei 5G for Medical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Huawei 5G for Medical Product Portfolio Table 107. Huawei Recent Development Table 108. ZTE Company Information Table 109. ZTE Business Overview Table 110. ZTE 5G for Medical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. ZTE 5G for Medical Product Portfolio Table 112. ZTE Recent Development Table 113. North America 5G for Medical Revenue by Type (2021-2026) & (US$ Million) Table 114. North America 5G for Medical Revenue by Type (2027-2032) & (US$ Million) Table 115. North America 5G for Medical Revenue by Application (2021-2026) & (US$ Million) Table 116. North America 5G for Medical Revenue by Application (2027-2032) & (US$ Million) Table 117. North America 5G for Medical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America 5G for Medical Revenue by Country (2021-2026) & (US$ Million) Table 119. North America 5G for Medical Revenue by Country (US$ Million) & (2027-2032) Table 120. Europe 5G for Medical Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe 5G for Medical Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe 5G for Medical Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe 5G for Medical Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe 5G for Medical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe 5G for Medical Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe 5G for Medical Revenue by Country (US$ Million) & (2027-2032) Table 127. China 5G for Medical Revenue by Type (2021-2026) & (US$ Million) Table 128. China 5G for Medical Revenue by Type (2027-2032) & (US$ Million) Table 129. China 5G for Medical Revenue by Application (2021-2026) & (US$ Million) Table 130. China 5G for Medical Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia 5G for Medical Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia 5G for Medical Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia 5G for Medical Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia 5G for Medical Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia 5G for Medical Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia 5G for Medical Revenue by Region (US$ Million) & (2021-2026) Table 137. Asia 5G for Medical Revenue by Region (US$ Million) & (2027-2032) Table 138. SAMEA 5G for Medical Revenue by Type (2021-2026) & (US$ Million) Table 139. SAMEA 5G for Medical Revenue by Type (2027-2032) & (US$ Million) Table 140. SAMEA 5G for Medical Revenue by Application (2021-2026) & (US$ Million) Table 141. SAMEA 5G for Medical Revenue by Application (2027-2032) & (US$ Million) Table 142. SAMEA 5G for Medical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. SAMEA 5G for Medical Revenue by Country (2021-2026) & (US$ Million) Table 144. SAMEA 5G for Medical Revenue by Country (US$ Million) & (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. 5G for Medical Image Figure 2. Global 5G for Medical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 5G for Medical Market Size Share 2021 VS 2025 VS 2032 Figure 4. Patient Monitoring Image Figure 5. Remote Diagnosis Image Figure 6. Robotic surgery (Procedures) Image Figure 7. Others(Remote Medical Learning) Image Figure 8. Global 5G for Medical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global 5G for Medical Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Home Healthcare Image Figure 12. Educational Institution Image Figure 13. Others Image Figure 14. Global 5G for Medical Market Size (US$ Million) & (2021-2032) Figure 15. Global 5G for Medical Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global 5G for Medical Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global 5G for Medical Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global 5G for Medical Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global 5G for Medical Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global 5G for Medical Revenue Market Share by Type (2021-2032) Figure 22. Global 5G for Medical Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global 5G for Medical Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global 5G for Medical Revenue Market Share by Application (2021-2032) Figure 25. North America 5G for Medical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America 5G for Medical Revenue Share by Type (2021-2032) Figure 27. North America 5G for Medical Revenue Share by Application (2021-2032) Figure 28. North America 5G for Medical Revenue Share by Country (2021-2032) Figure 29. United States 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe 5G for Medical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe 5G for Medical Revenue Share by Type (2021-2032) Figure 34. Europe 5G for Medical Revenue Share by Application (2021-2032) Figure 35. Europe 5G for Medical Revenue Share by Country (2021-2032) Figure 36. Germany 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China 5G for Medical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China 5G for Medical Revenue Share by Type (2021-2032) Figure 46. China 5G for Medical Revenue Share by Application (2021-2032) Figure 47. Asia 5G for Medical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia 5G for Medical Revenue Share by Type (2021-2032) Figure 49. Asia 5G for Medical Revenue Share by Application (2021-2032) Figure 50. Asia 5G for Medical Revenue Share by Region (2021-2032) Figure 51. Japan 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA 5G for Medical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA 5G for Medical Revenue Share by Type (2021-2032) Figure 59. SAMEA 5G for Medical Revenue Share by Application (2021-2032) Figure 60. SAMEA 5G for Medical Revenue Share by Country (2021-2032) Figure 61. Brazil 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt 5G for Medical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Patient Monitoring
  • Remote Diagnosis
  • Robotic surgery (Procedures)
  • Others(Remote Medical Learning)
Applications
  • Hospital
  • Home Healthcare
  • Educational Institution
  • Others
Companies covered
  • AT&T
  • Capsule Technologies
  • Microsoft
  • Intel Corporation
  • Cisco
  • Accenture
  • Verizon Communications
  • Ericsson
  • Oracle
  • Juniper Networks
  • Nokia
  • Samsung Electronics
  • NEC
  • Huawei
  • ZTE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 5G for Medical Market by Type
  3. 1.2.1 Global 5G for Medical Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Patient Monitoring
  5. 1.2.3 Remote Diagnosis
  6. 1.2.4 Robotic surgery (Procedures)
  7. 1.2.5 Others(Remote Medical Learning)
  8. 1.3 5G for Medical Market by Application
  9. 1.3.1 Global 5G for Medical Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Home Healthcare
  12. 1.3.4 Educational Institution
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 5G for Medical Market Dynamics
  1. 2.1 5G for Medical Industry Trends
  2. 2.2 5G for Medical Industry Drivers
  3. 2.3 5G for Medical Industry Opportunities and Challenges
  4. 2.4 5G for Medical Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global 5G for Medical Market Perspective (2021-2032)
  2. 3.2 Global 5G for Medical Growth Trends by Region
  3. 3.2.1 Global 5G for Medical Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global 5G for Medical Market Size by Region (2021-2026)
  5. 3.2.3 Global 5G for Medical Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global 5G for Medical Revenue by Players
  2. 4.1.1 Global 5G for Medical Revenue by Players (2021-2026)
  3. 4.1.2 Global 5G for Medical Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global 5G for Medical Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global 5G for Medical Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global 5G for Medical Key Players Headquarters & Area Served
  7. 4.4 Global 5G for Medical Players, Product Type & Application
  8. 4.5 Global 5G for Medical Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global 5G for Medical Market CR5 and HHI
  11. 4.6.3 2025 5G for Medical Tier 1, Tier 2, and Tier 3
5 5G for Medical Market Size by Type
  1. 5.1 Global 5G for Medical Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global 5G for Medical Revenue by Type (2021-2032)
  3. 5.3 Global 5G for Medical Revenue Market Share by Type (2021-2032)
6 5G for Medical Market Size by Application
  1. 6.1 Global 5G for Medical Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global 5G for Medical Revenue by Application (2021-2032)
  3. 6.3 Global 5G for Medical Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AT&T
  2. 7.1.1 AT&T Company Information
  3. 7.1.2 AT&T Business Overview
  4. 7.1.3 AT&T 5G for Medical Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AT&T 5G for Medical Product Portfolio
  6. 7.1.5 AT&T Recent Developments
  7. 7.2 Capsule Technologies
  8. 7.2.1 Capsule Technologies Company Information
  9. 7.2.2 Capsule Technologies Business Overview
  10. 7.2.3 Capsule Technologies 5G for Medical Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Capsule Technologies 5G for Medical Product Portfolio
  12. 7.2.5 Capsule Technologies Recent Developments
  13. 7.3 Microsoft
  14. 7.3.1 Microsoft Company Information
  15. 7.3.2 Microsoft Business Overview
  16. 7.3.3 Microsoft 5G for Medical Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Microsoft 5G for Medical Product Portfolio
  18. 7.3.5 Microsoft Recent Developments
  19. 7.4 Intel Corporation
  20. 7.4.1 Intel Corporation Company Information
  21. 7.4.2 Intel Corporation Business Overview
  22. 7.4.3 Intel Corporation 5G for Medical Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Intel Corporation 5G for Medical Product Portfolio
  24. 7.4.5 Intel Corporation Recent Developments
  25. 7.5 Cisco
  26. 7.5.1 Cisco Company Information
  27. 7.5.2 Cisco Business Overview
  28. 7.5.3 Cisco 5G for Medical Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cisco 5G for Medical Product Portfolio
  30. 7.5.5 Cisco Recent Developments
  31. 7.6 Accenture
  32. 7.6.1 Accenture Company Information
  33. 7.6.2 Accenture Business Overview
  34. 7.6.3 Accenture 5G for Medical Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Accenture 5G for Medical Product Portfolio
  36. 7.6.5 Accenture Recent Developments
  37. 7.7 Verizon Communications
  38. 7.7.1 Verizon Communications Company Information
  39. 7.7.2 Verizon Communications Business Overview
  40. 7.7.3 Verizon Communications 5G for Medical Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Verizon Communications 5G for Medical Product Portfolio
  42. 7.7.5 Verizon Communications Recent Developments
  43. 7.8 Ericsson
  44. 7.8.1 Ericsson Company Information
  45. 7.8.2 Ericsson Business Overview
  46. 7.8.3 Ericsson 5G for Medical Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ericsson 5G for Medical Product Portfolio
  48. 7.8.5 Ericsson Recent Developments
  49. 7.9 Oracle
  50. 7.9.1 Oracle Company Information
  51. 7.9.2 Oracle Business Overview
  52. 7.9.3 Oracle 5G for Medical Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Oracle 5G for Medical Product Portfolio
  54. 7.9.5 Oracle Recent Developments
  55. 7.10 Juniper Networks
  56. 7.10.1 Juniper Networks Company Information
  57. 7.10.2 Juniper Networks Business Overview
  58. 7.10.3 Juniper Networks 5G for Medical Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Juniper Networks 5G for Medical Product Portfolio
  60. 7.10.5 Juniper Networks Recent Developments
  61. 7.11 Nokia
  62. 7.11.1 Nokia Company Information
  63. 7.11.2 Nokia Business Overview
  64. 7.11.3 Nokia 5G for Medical Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Nokia 5G for Medical Product Portfolio
  66. 7.11.5 Nokia Recent Developments
  67. 7.12 Samsung Electronics
  68. 7.12.1 Samsung Electronics Company Information
  69. 7.12.2 Samsung Electronics Business Overview
  70. 7.12.3 Samsung Electronics 5G for Medical Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Samsung Electronics 5G for Medical Product Portfolio
  72. 7.12.5 Samsung Electronics Recent Developments
  73. 7.13 NEC
  74. 7.13.1 NEC Company Information
  75. 7.13.2 NEC Business Overview
  76. 7.13.3 NEC 5G for Medical Revenue and Gross Margin (2021-2026)
  77. 7.13.4 NEC 5G for Medical Product Portfolio
  78. 7.13.5 NEC Recent Developments
  79. 7.14 Huawei
  80. 7.14.1 Huawei Company Information
  81. 7.14.2 Huawei Business Overview
  82. 7.14.3 Huawei 5G for Medical Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Huawei 5G for Medical Product Portfolio
  84. 7.14.5 Huawei Recent Developments
  85. 7.15 ZTE
  86. 7.15.1 ZTE Company Information
  87. 7.15.2 ZTE Business Overview
  88. 7.15.3 ZTE 5G for Medical Revenue and Gross Margin (2021-2026)
  89. 7.15.4 ZTE 5G for Medical Product Portfolio
  90. 7.15.5 ZTE Recent Developments
8 North America
  1. 8.1 North America 5G for Medical Revenue (2021-2032)
  2. 8.2 North America 5G for Medical Revenue by Type (2021-2032)
  3. 8.2.1 North America 5G for Medical Revenue by Type (2021-2026)
  4. 8.2.2 North America 5G for Medical Revenue by Type (2027-2032)
  5. 8.3 North America 5G for Medical Revenue Share by Type (2021-2032)
  6. 8.4 North America 5G for Medical Revenue by Application (2021-2032)
  7. 8.4.1 North America 5G for Medical Revenue by Application (2021-2026)
  8. 8.4.2 North America 5G for Medical Revenue by Application (2027-2032)
  9. 8.5 North America 5G for Medical Revenue Share by Application (2021-2032)
  10. 8.6 North America 5G for Medical Revenue by Country
  11. 8.6.1 North America 5G for Medical Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America 5G for Medical Revenue by Country (2021-2026)
  13. 8.6.3 North America 5G for Medical Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe 5G for Medical Revenue (2021-2032)
  2. 9.2 Europe 5G for Medical Revenue by Type (2021-2032)
  3. 9.2.1 Europe 5G for Medical Revenue by Type (2021-2026)
  4. 9.2.2 Europe 5G for Medical Revenue by Type (2027-2032)
  5. 9.3 Europe 5G for Medical Revenue Share by Type (2021-2032)
  6. 9.4 Europe 5G for Medical Revenue by Application (2021-2032)
  7. 9.4.1 Europe 5G for Medical Revenue by Application (2021-2026)
  8. 9.4.2 Europe 5G for Medical Revenue by Application (2027-2032)
  9. 9.5 Europe 5G for Medical Revenue Share by Application (2021-2032)
  10. 9.6 Europe 5G for Medical Revenue by Country
  11. 9.6.1 Europe 5G for Medical Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe 5G for Medical Revenue by Country (2021-2026)
  13. 9.6.3 Europe 5G for Medical Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China 5G for Medical Revenue (2021-2032)
  2. 10.2 China 5G for Medical Revenue by Type (2021-2032)
  3. 10.2.1 China 5G for Medical Revenue by Type (2021-2026)
  4. 10.2.2 China 5G for Medical Revenue by Type (2027-2032)
  5. 10.3 China 5G for Medical Revenue Share by Type (2021-2032)
  6. 10.4 China 5G for Medical Revenue by Application (2021-2032)
  7. 10.4.1 China 5G for Medical Revenue by Application (2021-2026)
  8. 10.4.2 China 5G for Medical Revenue by Application (2027-2032)
  9. 10.5 China 5G for Medical Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia 5G for Medical Revenue (2021-2032)
  2. 11.2 Asia 5G for Medical Revenue by Type (2021-2032)
  3. 11.2.1 Asia 5G for Medical Revenue by Type (2021-2026)
  4. 11.2.2 Asia 5G for Medical Revenue by Type (2027-2032)
  5. 11.3 Asia 5G for Medical Revenue Share by Type (2021-2032)
  6. 11.4 Asia 5G for Medical Revenue by Application (2021-2032)
  7. 11.4.1 Asia 5G for Medical Revenue by Application (2021-2026)
  8. 11.4.2 Asia 5G for Medical Revenue by Application (2027-2032)
  9. 11.5 Asia 5G for Medical Revenue Share by Application (2021-2032)
  10. 11.6 Asia 5G for Medical Revenue by Country
  11. 11.6.1 Asia 5G for Medical Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia 5G for Medical Revenue by Country (2021-2026)
  13. 11.6.3 Asia 5G for Medical Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA 5G for Medical Revenue (2021-2032)
  2. 12.2 SAMEA 5G for Medical Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA 5G for Medical Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA 5G for Medical Revenue by Type (2027-2032)
  5. 12.3 SAMEA 5G for Medical Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA 5G for Medical Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA 5G for Medical Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA 5G for Medical Revenue by Application (2027-2032)
  9. 12.5 SAMEA 5G for Medical Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA 5G for Medical Revenue by Country
  11. 12.6.1 SAMEA 5G for Medical Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA 5G for Medical Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA 5G for Medical Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research